
Expand
Updated
Novo said its Wegovy injection lowered body mass index and obesity rates in children in a trial, CNBC Top News reported on November 16, 2026. Wegovy is already approved to treat obesity in children ages 12 and older. There are currently no approved medications for children under 12.
Sources:CNBC Top News